欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/1091/002
药品名称Venlafaxine Retard Mylan 75 mg, capsules met verlengde afgifte
活性成分
    • venlafaxine 37.5 mg
剂型Prolonged-release capsule, hard
上市许可持有人Mylan Pharmaceuticals Limited Damastown Industrial Park, Mulhuddart Dublin 15, Dublin Ireland
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      VENLAFAXINE/GENERICS
    • Poland (PL)
      Faxigen XL 75 mg
    • Czechia (CZ)
    • Sweden (SE)
许可日期2008/05/21
最近更新日期2024/04/17
药物ATC编码
    • N06AX16 venlafaxine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase